310 related articles for article (PubMed ID: 31115044)
1. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Song Y; Wang Y; Wang Z
Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044
[TBL] [Abstract][Full Text] [Related]
2. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
[TBL] [Abstract][Full Text] [Related]
7. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
Song Y; Wang J; Wang Y; Wu L; Wang Z
Cancer Biol Ther; 2021 Dec; 22(10-12):598-606. PubMed ID: 34724875
[TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K
Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center.
Imashuku S; Kuriyama K; Sakai R; Nakao Y; Masuda S; Yasuda N; Kawano F; Yakushijin K; Miyagawa A; Nakao T; Teramura T; Tabata Y; Morimoto A; Hibi S
Med Pediatr Oncol; 2003 Aug; 41(2):103-9. PubMed ID: 12825212
[TBL] [Abstract][Full Text] [Related]
10. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus.
Ueda T; Itabashi T; Yamanishi S; Tanabe Y; Migita M; Itoh Y
J Nippon Med Sch; 2020 Jul; 87(3):166-170. PubMed ID: 32238729
[TBL] [Abstract][Full Text] [Related]
11. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
[TBL] [Abstract][Full Text] [Related]
12. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
[TBL] [Abstract][Full Text] [Related]
13. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Br J Haematol; 2020 Nov; 191(3):453-459. PubMed ID: 32525580
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Lee JS; Kang JH; Lee GK; Park HJ
J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.
Pan H; Feng DN; Song L; Sun LR
BMC Pediatr; 2016 Jul; 16():116. PubMed ID: 27473573
[TBL] [Abstract][Full Text] [Related]
16. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.
Lehmberg K; Sprekels B; Nichols KE; Woessmann W; Müller I; Suttorp M; Bernig T; Beutel K; Bode SF; Kentouche K; Kolb R; Längler A; Minkov M; Schilling FH; Schmid I; Vieth S; Ehl S; Zur Stadt U; Janka GE
Br J Haematol; 2015 Aug; 170(4):539-49. PubMed ID: 25940575
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
Jin Z; Wang Y; Wei N; Wang Z
Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
19. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
20. Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.
Qin Q; Xie Z; Shen Y; Yang S; Liu C; Huang Z; Xu J; Al J; Shen K
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):672-8. PubMed ID: 22774410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
